Hints and tips:
Related Special Reports
Related Topics
...Dean Li, president of Merck’s research laboratories, praised the UK’s scientific talent and expertise, hoping that the investment in King’s Cross will help researchers at MSD, known as Merck in the US, work...
...MSD, known as Merck in the US, expects competition for its Keytruda cancer treatment from late 2028. Sales of Eliquis, a small molecule pill, are expected to top $13bn in 2025....
...A person familiar with the process said Merck “understood there was no hope . . . [Lagevrio] is a bit burnt”....
...TSMC said it “maintains a strong and close partnership with its suppliers, which includes open communication channels and strict co-operation on technology confidentiality management”....
...He said Merck’s claim that the reforms were an “extortion” was accurate....
...Investors have also questioned the relationship with Blackstone, which both co-owns the management company for Hipgnosis as well as a rival fund that is still buying song rights....
...Molnupiravir, marketed by Merck and co-developed with US biotech group Ridgeback Biotherapeutics, works by inducing small mutations in the virus itself....
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...Merck is either optimistic or desperate if it is willing to pay $5bn more than Prometheus’ valuation three days ago. But it has the funds....
...Under the terms of the transaction Merck is acquiring Prometheus through a subsidiary....
...And what are the incentives of Merck Mercuriadis after the transaction?...
...When Ken Frazier, another law school friend, was CEO of Merck and facing criticism for refusing to cut research budgets, Ogunlesi reassured him he was doing the right thing....
...His efforts included a conversation with an unnamed “board member I knew at BI” and approaches to KKR co-founder Henry Kravis, its co-CEO Joseph Bae and Axel Springer’s Döpfner....
...FY, Brunswick Q4, BT Group Q3 trading update, Coursera Q4, Dassault Systèmes Q4, Icelandair Q4, ING Q4, International Paper Q4, Glencore Q4 production report, Hartford Financial Services Q4, Konami Q3, Merck...
...Investors object to the price offered by Blackstone, which also co-owns the company that manages HSF, as well as a lack of transparency over the costs of the deal....
...But the FT reported that months earlier, Merck, a German healthcare and life sciences group, had proposed buying a majority stake in the Japanese company....
...Blackstone announced that it had set aside $1bn to buy music in partnership with Merck Mercuriadis’s Hipgnosis investment trust, noting his “vision and dynamism”....
...Job moves JPMorgan Chase has named Carsten Woehrn, who was promoted to co-head of mergers and acquisitions for Europe, the Middle East and Africa earlier this month, to global co-head of M&A for its strategic...
...Former Merck & Co chief executive Kenneth Frazier and KKR co-chief executive Joseph Bae will join the Harvard Corporation. Goldman Sachs is shuffling its powerful management committee....
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
...“When appropriate, Merck seek to protect its additional innovation,” he added. Merck said it continued to point to late 2028 as the most likely timeframe for biosimilar entry into the market....
...Weber is a paid consultant for Merck and Moderna....
...And earlier this week, New Jersey pharma titan Merck paid a 75 per cent premium on its $10.8bn deal to buy Prometheus Biosciences. There’s a method to Merck’s madness....
...Only a few, including TSMC, Merck and Bosch, said they had a long-term reduction plan to eliminate the chemicals. Intel has pledged no “new” PFAS use in its supply chain....
...Merck called for the UK government to do more to support the pharma industry as it opened a £1bn research centre in London....
International Edition